Vivo Bio Tech, a company in the Biotechnology industry, reported revenue of ₹17 crore and net profit of ₹1.10 crore for the September 2026 quarter.
Vivo Bio Tech (NSE: VIVOBIOT) closed at ₹16.01 on 20 Nov 2026. Its market capitalisation is ₹36 crore.
Incorporated in 1987, Vivo Bio Tech Ltd is engaged in service of CRO offering Drug Development & Discovery Services to Pharmaceutical & Biotech Companies
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.